Central Trust Company’s Insmed INSM Stock Holding History

Central Trust Company’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.39K	Buy	13 +10	+333%	+$1.21K	﹤0.01%	1455
2026 Q1	$491	Hold	3	–	–	﹤0.01%	1495
2025 Q4	$523	Buy	+3	New	+$547	﹤0.01%	1440
2022 Q3	–	Sell	-15	Closed	–	–	1357
2022 Q2	$0	Hold	15	–	–	﹤0.01%	1409
2022 Q1	$0	Sell	15 -285	-95%	-$6.62K	﹤0.01%	1415
2021 Q4	$8K	Hold	300	–	–	﹤0.01%	1085
2021 Q3	$8K	Hold	300	–	–	﹤0.01%	1071
2021 Q2	$9K	Buy	+300	New	+$8.9K	﹤0.01%	1037

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Central Trust Company's INSM Position: Q2 2026 in Review

Central Trust Company increased its Insmed (INSM) stake by 333% in Q2 2026, buying an estimated $1.21K and bringing the position to 13 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1455.

Central Trust Company first reported a position in INSM in Q2 2021 and has held it in 8 quarters since. The position peaked at $9K in Q2 2021. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Central Trust Company held 13 shares of Insmed worth $1.39K as of Q2 2026.
Central Trust Company bought 10 Insmed shares in Q2 2026, an estimated $1.21K.
Insmed made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1455 holding.
Central Trust Company first reported a position in Insmed in Q2 2021 and has held it in 8 quarters since.
Central Trust Company's Insmed position peaked at $9K in Q2 2021.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.